182 related articles for article (PubMed ID: 36717550)
21. Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis.
Del Rio D; Masi I; Caprara V; Spadaro F; Ottavi F; Strippoli R; Sandoval P; López-Cabrera M; Sainz de la Cuesta R; Bagnato A; Rosanò L
Front Cell Dev Biol; 2021; 9():764375. PubMed ID: 34926453
[TBL] [Abstract][Full Text] [Related]
22. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition.
Tocci P; Roman C; Sestito R; Di Castro V; Sacconi A; Molineris I; Paolini F; Carosi M; Tonon G; Blandino G; Bagnato A
Cell Death Dis; 2023 Jan; 14(1):5. PubMed ID: 36604418
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.
Bagnato A; Rosanò L
Small GTPases; 2018 Sep; 9(5):394-398. PubMed ID: 27690729
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
25. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
26. Integrin affinity modulation critically regulates atherogenic endothelial activation in vitro and in vivo.
Al-Yafeai Z; Pearson BH; Peretik JM; Cockerham ED; Reeves KA; Bhattarai U; Wang D; Petrich BG; Orr AW
Matrix Biol; 2021 Feb; 96():87-103. PubMed ID: 33157226
[TBL] [Abstract][Full Text] [Related]
27. Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.
Tocci P; Cianfrocca R; Sestito R; Rosanò L; Di Castro V; Blandino G; Bagnato A
Cancer Lett; 2020 Nov; 492():84-95. PubMed ID: 32860850
[TBL] [Abstract][Full Text] [Related]
28. Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis.
Rosanò L; Cianfrocca R; Masi S; Spinella F; Di Castro V; Biroccio A; Salvati E; Nicotra MR; Natali PG; Bagnato A
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2806-11. PubMed ID: 19202075
[TBL] [Abstract][Full Text] [Related]
29. [Study of the clinical significance of ETAR mRNA expression in high-grade serous ovarian cancer and the inhibitory effect of ETAR derived fusion polypeptide on cancer progression].
Zhang YL; Xia XK; Zhang M
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):930-938. PubMed ID: 38123199
[No Abstract] [Full Text] [Related]
30. Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.
Sestito R; Cianfrocca R; Tocci P; Rosanò L; Sacconi A; Blandino G; Bagnato A
Commun Biol; 2020 Nov; 3(1):677. PubMed ID: 33188287
[TBL] [Abstract][Full Text] [Related]
31. Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin.
Deng B; Zhang S; Miao Y; Han Z; Zhang X; Wen F; Zhang Y
J Exp Clin Cancer Res; 2012 Mar; 31(1):19. PubMed ID: 22400488
[TBL] [Abstract][Full Text] [Related]
32. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.
Iwanicki MP; Davidowitz RA; Ng MR; Besser A; Muranen T; Merritt M; Danuser G; Ince TA; Brugge JS
Cancer Discov; 2011 Jul; 1(2):144-57. PubMed ID: 22303516
[TBL] [Abstract][Full Text] [Related]
33. Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma.
Dong Y; Tan OL; Loessner D; Stephens C; Walpole C; Boyle GM; Parsons PG; Clements JA
Cancer Res; 2010 Apr; 70(7):2624-33. PubMed ID: 20332224
[TBL] [Abstract][Full Text] [Related]
34. Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis.
Jin JK; Tien PC; Cheng CJ; Song JH; Huang C; Lin SH; Gallick GE
Oncogene; 2015 Apr; 34(14):1811-21. PubMed ID: 24793790
[TBL] [Abstract][Full Text] [Related]
35. YAP and endothelin-1 signaling: an emerging alliance in cancer.
Tocci P; Blandino G; Bagnato A
J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
[TBL] [Abstract][Full Text] [Related]
36. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways.
Luo DH; Chen QY; Liu H; Xu LH; Zhang HZ; Zhang L; Tang LQ; Mo HY; Huang PY; Guo X; Mai HQ
J Transl Med; 2013 Aug; 11():203. PubMed ID: 23987636
[TBL] [Abstract][Full Text] [Related]
37. G protein- and
Xiong X; Nazo N; Revoori R; Rajagopal S; Sparks MA
Kidney360; 2021 Jul; 2(7):1124-1131. PubMed ID: 35368349
[TBL] [Abstract][Full Text] [Related]
38. A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling.
Zhuo Y; Gurevich VV; Vishnivetskiy SA; Klug CS; Marchese A
J Biol Chem; 2020 Oct; 295(41):14111-14124. PubMed ID: 32753481
[TBL] [Abstract][Full Text] [Related]
39. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
[TBL] [Abstract][Full Text] [Related]
40. β-Arrestin1 alleviates acute pancreatitis via repression of NF-κBp65 activation.
Tao L; Lin X; Tan S; Lei Y; Liu H; Guo Y; Zheng F; Wu B
J Gastroenterol Hepatol; 2019 Jan; 34(1):284-292. PubMed ID: 30144357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
